Company / Cash per Share
VitaNova Life Sciences Corp Cash per Share History
FY2018-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.00
FY2023
5-year range
$0.00 / $0.00
FY2019-FY2023
Trend
-62.2%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.00 to $0.00 over the past 2 years.
Based on SEC 10-K filings.
0.00 in FY2023 with a 5-year CAGR of +3.3%.
Improved from $0.00 to $0.00 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +3.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, cash per share decreased 62.2% year-over-year.
- Peak cash per share was recorded in FY2022.
- Lowest cash per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.00 | -62.2% |
| FY2022 | $0.00 | - |
| FY2021 | $0.00 | - |
| FY2020 | $0.00 | - |
| FY2019 | $0.00 | -100.0% |
| FY2018 | $0.00 | - |
As of FY2023 · SEC 10-K · Updated Jun 29, 2026